| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10900009 | Cancer Letters | 2013 | 10 Pages |
Abstract
⺠Doxorubicin encapsulating human serum albumin nanoparticles (HSA + DOX NPs) were fabricated to confirm the benefit of nanoparticles at the treatment of anoikis-resistant breast cancer cells. ⺠HSA + DOX NPs were more cytotoxic to anoikis-resistant cancer cells than free doxorubicin. ⺠HSA + DOX NPs delivered more doxorubicin into cells compared to the free doxorubicin by bypassing the drug efflux pump systems of anoikis-resistant cancer cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hohyeon Lee, Sunyoung Park, Jong Bin Kim, Jungwook Kim, Hyuncheol Kim,